| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |